Seqens Seqens

X

Digital content for Italfarmaco S.p.A

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Italfarmaco S.p.A
Italy Flag
Country
Country
Italy
Address
Address
V.le Fulvio Testi, 330 20126 Milan
Telephone
Telephone
02 64431
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/fda-approves-nonsteroidal-treatment-for-duchenne-muscular-dystrophy-302096571.html

PR NEWSWIRE
21 Mar 2024

https://www.businesswire.com/news/home/20240319626593/en

BUSINESSWIRE
19 Mar 2024

https://www.businesswire.com/news/home/20231214543204/en

BUSINESSWIRE
14 Dec 2023

https://www.businesswire.com/news/home/20230905089037/en

BUSINESSWIRE
05 Sep 2023

https://www.businesswire.com/news/home/20220727005429/en

BUSINESSWIRE
27 Jul 2022

https://www.businesswire.com/news/home/20220625005001/en

BUSINESSWIRE
25 Jun 2022

https://www.businesswire.com/news/home/20210626005019/en

BUSINESSWIRE
26 Jun 2021

https://www.businesswire.com/news/home/20210318005370/en

BUSINESSWIRE
18 Mar 2021

https://www.biospace.com/article/releases/italfarmaco-group-enters-into-an-agreement-with-luye-pharma-to-commercialize-alzheimer-s-disease-treatment-rivastigmine-multi-day-transdermal-patch-in-four-european-countries/

BIOSPACE
16 Mar 2021

https://www.biospace.com/article/releases/italfarmaco-receives-fda-rare-pediatric-disease-designation-for-givinostat-in-duchenne-muscular-dystrophy-announces-completed-enrollment-in-epidys-phase-3-trial/

BIOSPACE
09 Oct 2020
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY